Cargando…

Approach to Dyslipidemia, Lipodystrophy, and Cardiovascular Risk in Patients with HIV Infection

There is a significant prevalence (20%–80% depending on the population and the study) of lipid disorders and other cardiovascular risk factors in people living with HIV infection. This review focuses on HIV and HIV treatment–associated metabolic and cardiovascular concerns, including dyslipidemias,...

Descripción completa

Detalles Bibliográficos
Autor principal: Troll, J. Gregory
Formato: Texto
Lenguaje:English
Publicado: Current Science Inc. 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018260/
https://www.ncbi.nlm.nih.gov/pubmed/21181310
http://dx.doi.org/10.1007/s11883-010-0152-1